These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 23181623)
41. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779 [TBL] [Abstract][Full Text] [Related]
42. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder. Spradling K; Lotan Y; Shokeir A; Abol-Enein H; Mosbah A; Morgan JB; Ghoneim M; Youssef RF Urol Oncol; 2016 Sep; 34(9):417.e1-8. PubMed ID: 27157247 [TBL] [Abstract][Full Text] [Related]
43. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Wright JL; Lin DW; Porter MP Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515 [TBL] [Abstract][Full Text] [Related]
44. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer. Branchereau J; Larue S; Vayleux B; Karam G; Bouchot O; Rigaud J Clin Genitourin Cancer; 2013 Jun; 11(2):182-8. PubMed ID: 23276589 [TBL] [Abstract][Full Text] [Related]
46. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803 [TBL] [Abstract][Full Text] [Related]
49. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy. May M; Brookman-May S; Burger M; Gilfrich C; Fritsche HM; Rink M; Chun F; Fisch M; Roghmann F; Noldus J; Mayr R; Pycha A; Novotny V; Wirth M; Vallo S; Haferkamp A; Roigas J; Brisuda A; Stredele R; Volkmer B; Dechet C; Schnabel M; Denzinger S; Stief CG; Bastian PJ; Aziz A Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114 [TBL] [Abstract][Full Text] [Related]
50. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Margulis V; Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y Clin Cancer Res; 2006 Dec; 12(24):7369-73. PubMed ID: 17189409 [TBL] [Abstract][Full Text] [Related]
51. Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma. Nakagawa T; Kanai Y; Nakanishi H; Komiyama M; Fujimoto H Jpn J Clin Oncol; 2012 Nov; 42(11):1066-72. PubMed ID: 22914320 [TBL] [Abstract][Full Text] [Related]
52. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. Mitra AP; Skinner EC; Miranda G; Daneshmand S BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881 [TBL] [Abstract][Full Text] [Related]
53. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623 [TBL] [Abstract][Full Text] [Related]